DocumentUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM SD
SPECIALIZED DISCLOSURE REPORT
SHOCKWAVE MEDICAL, INC.
(Exact Name of Registrant as Specified in its Charter)
| | | | | | | | | | | | | | |
| | | | |
Delaware | | 001-38829 | | 27-0494101 |
(State or other jurisdiction of incorporation or organization) | | (Commission File Number) | | (IRS Employer Identification No.) |
| | | | | | | | |
| | |
5403 Betsy Ross Drive, Santa Clara, California | | 95054 |
(Address of Principal Executive Offices) | | (Zip Code) |
Hajime Tada
General Counsel
(510) 279-4262
(Name and telephone number, including area code, of the person to contact in connection with this report.)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:
| | | | | |
x | Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period January 1, 2022 to December 31, 2022 |
| | | | | |
Item 1.01. | Conflict Minerals Disclosure and Report. |
A copy of the Conflict Minerals Report of Shockwave Medical, Inc. (“Shockwave”) for the reporting period January 1, 2022 to December 31, 2022 is filed as Exhibit 1.01 to this specialized disclosure report on Form SD and is also available at Shockwave’s website at https://ir.shockwavemedical.com/financial-information/sec-filings.
Shockwave has filed, as an exhibit to this Form SD, a Conflict Minerals Report as required by Item 1.01 of this Form.
| | | | | | | | |
| | |
Exhibit Number | | Description of Document |
| |
| | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
| | | | | | | | | | | | | | |
| | | | |
| | | | SHOCKWAVE MEDICAL, INC. |
| | |
Dated: May 26, 2023 | | By: | | /s/ Daniel Puckett |
| | Name: | | Daniel Puckett |
| | Title: | | Chief Financial Officer |